These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 30024524)

  • 1. Symptom relief for patients with diarrhoeal irritable bowel syndrome with anxiety and depression.
    Chen P; Wang X; Hou L; Luo Y
    Asian J Surg; 2024 Jul; 47(7):3113-3114. PubMed ID: 38490867
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcutaneous electric nerve stimulation over acupoints for patients with diarrhea-predominant irritable bowel syndrome: Protocol for systematic review and meta-analysis.
    Han BY; Shao QF; Cong Y; Guo S; Mao XY; Wei RH; Wei W
    Medicine (Baltimore); 2018 Dec; 97(51):e13267. PubMed ID: 30572430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acupuncture for diarrhea-predominant irritable bowel syndrome:a meta-analysis].
    Deng D; Guo K; Tan J; Huang G; Li S; Jiang Q; Xie J; Xie H; Zhang Z; Chen Y; Peng L
    Zhongguo Zhen Jiu; 2017 Aug; 37(8):907-912. PubMed ID: 29231356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable Bowel Syndrome and Female Patients.
    Harris LA; Umar SB; Baffy N; Heitkemper MM
    Gastroenterol Clin North Am; 2016 Jun; 45(2):179-204. PubMed ID: 27261893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular electrical stimulation as an adjunctive therapy to drotaverine hydrochloride for treating patients with diarrhea-predominant irritable bowel syndrome: A retrospective study.
    Wang JK; Liu J
    Medicine (Baltimore); 2018 Jul; 97(29):e11478. PubMed ID: 30024524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled study of efficacy and safety of drotaverine hydrochloride in patients with irritable bowel syndrome.
    Xue XC; Qi XX; Wan XY
    Medicine (Baltimore); 2017 Dec; 96(51):e9235. PubMed ID: 29390477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial.
    Zheng H; Li Y; Zhang W; Zeng F; Zhou SY; Zheng HB; Zhu WZ; Jing XH; Rong PJ; Tang CZ; Wang FC; Liu ZB; Wang SJ; Zhou MQ; Liu ZS; Zhu B
    Medicine (Baltimore); 2016 Jun; 95(24):e3884. PubMed ID: 27310980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: a randomized double-blind placebo-controlled study.
    Rai RR; Dwivedi M; Kumar N
    Saudi J Gastroenterol; 2014; 20(6):378-82. PubMed ID: 25434320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study.
    Coban Ş; Akbal E; Köklü S; Köklü G; Ulaşlı MA; Erkeç S; Aktaş B; Yüksel O; Koçak E; Erdem HR
    Digestion; 2012; 86(2):86-93. PubMed ID: 22846190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year follow-up of sacral nerve stimulation for patients with diarrhoea-predominant and mixed irritable bowel syndrome.
    Fassov J; Lundby L; Laurberg S; Buntzen S; Krogh K
    Colorectal Dis; 2017 Feb; 19(2):188-193. PubMed ID: 27328645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
    Li DY; Dai YK; Zhang YZ; Huang MX; Li RL; Ou-Yang J; Chen WJ; Hu L
    PLoS One; 2017; 12(12):e0189491. PubMed ID: 29253850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment.
    Defrees DN; Bailey J
    Prim Care; 2017 Dec; 44(4):655-671. PubMed ID: 29132527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary fiber in irritable bowel syndrome (Review).
    El-Salhy M; Ystad SO; Mazzawi T; Gundersen D
    Int J Mol Med; 2017 Sep; 40(3):607-613. PubMed ID: 28731144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the multiple symptoms of irritable bowel syndrome.
    Simrén M; Törnblom H; Palsson OS; Whitehead WE
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):112-122. PubMed ID: 28403981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats.
    Ma X; Wang X; Kang N; Chen T; Ji H; Lv L; Yin X; Tian Y; Zheng R; Duan Y; Wang F; Tang X
    Evid Based Complement Alternat Med; 2017; 2017():9086034. PubMed ID: 28331524
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.